Beijing Konruns Pharmaceut (603590.SS) traded flat 0 % during a 24 hours period ending at 07:20 PM Central Europe on Monday 26th. One Beijing Konruns Pharmaceut stock can currently be bought for about CNY 27.65 on popular exchanges. Current supply of Beijing Konruns Pharmaceut stocks is 157.1 mn. Beijing Konruns Pharmaceut has a current market capitalization of CNY 4.3 bn and approximately CNY 73.5 mn worth of Beijing Konruns Pharmaceut was traded on exchanges in the last 24 hours. Since last month end, Beijing Konruns Pharmaceut has traded -6.19 % down. Simple moving average of last 200 days is at CNY 30.82. The highest price of past 52 weeks was recorded at CNY 50.76 on 11/03/2025. 52 weeks low was at CNY 26.32 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Shenzhen Baoming Technolog (002992.SZ) traded flat 0 % and now trades at CNY 28.41. Current market capitalisation for Shenzhen Baoming Technolog is CNY 5.2 bn. Shenzhen Baoming Technolog has a current price to earnings ratio of 1,667.11.
Hangzhou Jiebai (600814.SS) traded flat 0 % and now trades at CNY 7.04. Hangzhou Jiebai has a market capitalisation of CNY 5.2 bn. Hangzhou Jiebai has a current price to earnings ratio of 22.32.
Vontron (000920.SZ) traded flat 0 % and now trades at CNY 11.1. Vontron has a market capitalisation of CNY 5.2 bn. Vontron has a current price to earnings ratio of 22.52. VONTRON TECHNOLOGY CO reported that its first three quarters of 2026 saw a modest rise in revenue while its profitability improved noticeably. The company highlighted stronger earnings in the third quarter, attributing the growth to a shift toward higher‑margin products and tighter cost controls. Concurrently, VONTRON announced a significant expansion plan: a fully owned subsidiary will invest several hundred million yuan to build new production lines for membrane materials, membrane assemblies, and poly‑aryl‑ether‑sulfone. Once completed, the facility will add considerable capacity across key components of the membrane supply chain, enhancing integration, reducing dependence on external raw‑material suppliers, and strengthening the firm’s position in the high‑end membrane market. Management acknowledged that the project’s long construction period could expose the company to macroeconomic and regulatory uncertainties and stated it would manage these risks proactively.
Zhejiang Jiaao Enprotech Stock (603822.SS) traded flat 0 % and now trades at CNY 67.58. Zhejiang Jiaao Enprotech Stock has a market capitalisation of CNY 5.2 bn. Zhejiang Jiaao Enprotech Stock has a current price to earnings ratio of 30.17.
Allmed Medical Products (002950.SZ) traded flat 0 % and now trades at CNY 8.39. Current market capitalisation for Allmed Medical Products is CNY 5.2 bn. Current price/earnings ratio for Allmed Medical Products is 20.93.
About Beijing Konruns Pharmaceut
Beijing Konruns Pharmaceutical Co., Ltd. is a health care sector company based in Beijing, China. The company specializes in conducting research, manufacturing, and distributing pharmaceutical products. They produce freeze-dried powder injections, raw material medicines, and related products. Beijing Konruns Pharmaceutical markets its products globally. The company’s website is www.konruns.cn , and it is listed on the Shanghai Stock Exchange.